France bans oral nicotine products; BAT and Philip Morris slam “counterproductive” move, health groups applaud

Sep.08.2025
France has banned producing, importing, distributing, and consuming oral nicotine products (e.g., nicotine pouches, gum) without parliamentary debate or multi-stakeholder consultation. This has sparked strong opposition from firms like British American Tobacco France and Philip Morris France, which argue it contradicts EU discussions, deprives smokers of reduced-harm alternatives, and lacks scientific basis. However, anti-smoking group Alliance Contre le Tabac hails it as a "victory" for public

Key Points:


·France’s ban covers oral nicotine products, implemented without parliamentary debate or broad consultation.

·Tobacco firms criticize the move as conflicting with EU processes, risking EU market distortion, and denying 14 million French smokers regulated alternatives, contrary to "Europe's Beating Cancer" goals.

·Philip Morris France’s president slams it as an "ostrich policy" that could fuel black markets, harm youth protection, and cut tax revenues; calls for science-based, democratic policy-making.

·Anti-smoking group Alliance Contre le Tabac praises the ban as crucial to protecting youth and countering industry "addictive market" strategies, arguing such products expand nicotine addiction rather than aid cessation.

·Firms note the U.S. and Sweden have embraced such products with positive outcomes, while France’s ban is seen as short-sighted and isolating.

 


 

2Firsts, September 8th - according to lemondedutabac and afp, France recently passed a decree prohibiting the production, import, distribution, and consumption of oral nicotine-containing products (such as nicotine pouches and gum). Implemented without parliamentary debate or multi-stakeholder consultation, the ban has drawn strong opposition from companies including British American Tobacco France and Philip Morris France.

 

Both companies point out that the move runs counter to ongoing discussions at the European level, risks distorting the internal EU market, and deprives 14 million adult smokers in France of access to regulated, reduced-harm alternatives, contradicting the public health goals of the "Europe's Beating Cancer" strategy. They emphasize that the United States has approved the sale of such products following scientific evaluations, and Sweden, by promoting related alternatives, has become a country with an extremely low smoking rate. France's ban, however, lacks scientific basis and ignores these successful experiences.

 

Xavier Piesch, President of Philip Morris France, criticized the ban as an "ostrich policy," arguing it will fuel the unregulated black market, hinder efforts to protect minors, deprive adult smokers of opportunities to quit smoking, and reduce tax revenues. 

 

British American Tobacco France, meanwhile, called for transparent and democratic debates to formulate policies based on scientific assessments, rather than hastily implementing counterproductive bans. Additionally, businesses contend that the government's decision to bypass parliament and existing regulatory standards to enforce the ban is a short-sighted and isolated move that will leave France lagging in tobacco control efforts.

 

The Alliance Contre le Tabac (L'Alliance contre le tabac), a federation of anti-smoking associations, hailed the decision as a "victory."

 

"This is a crucial move to protect young people and combat the harmful strategies of an industry that thrives on an addictive market at the expense of public health," the group said in a statement.

 

"In the face of declining cigarette consumption in developed countries, nicotine pouches and new nicotine products (heated tobacco and e-cigarettes) are a new profit haven for cigarette manufacturers," the group said. For these manufacturers, "nicotine pouches and their derivatives (pellets, beads), far from being smoking cessation tools, simply serve to expand the market for nicotine addiction."

 

Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona's First Things First is pushing for an excise tax equal to 50% of the retail price of vaping products, estimating that the measure could generate about $100 million annually. The agency says its tobacco-tax revenue has fallen 47% from 2008 levels. Arizona has attempted to broaden its nicotine tax base in each of the past two years: a 2025 bill proposed a 50% wholesale-price tax, while a 2026 measure shifted to a 50% retail-price tax covering alternative nicotine products and vapor products. Separately, the state enacted HB 4001 this year to establish a new licensing and sales framework for alternative nicotine products.
Sep.21
Malaysia Police Seize RM12.7 Million in Illegal Vapes and Cigarettes as Probe Points to Sea Shipments From China
Malaysia Police Seize RM12.7 Million in Illegal Vapes and Cigarettes as Probe Points to Sea Shipments From China
Police in Malaysia’s Selangor state seized illegal vape products and contraband cigarettes worth about RM12.7 million (approximately $3 million) in two enforcement operations. According to New Straits Times and The Star, the vape-related operation uncovered 131,036 boxes of vape products, 4,900 bottles of e-liquid and 25,510 vape devices, valued at about RM9.4 million. Police said preliminary investigations indicated that some illegal vape products entered Malaysia through sea shipments from China before moving through storage and distribution networks.
Aug.10
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
R.J. Reynolds Vapor Company has introduced Vuse Pro prefilled pods in Peach, Berry, Watermelon and Fresh Mint in selected U.S. states. Vuse’s U.S. website says the pods are intended for use with existing Vuse Alto devices. Each contains 2.0 mL of e-liquid at 5.0% nicotine by weight, uses nicotine salts and is offered in two- and four-pod packs. Reynolds said the rollout includes mandatory ID scanning for every purchase, purchase limits, stronger retailer-accountability requirements and strict age-restricted marketing standards. The four pods have not received marketing authorization from the U.S. Food and Drug Administration.
Sep.10
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus distributor H&S said the zero-nicotine, zero-tar NEO vaping line will begin rolling out across FamilyMart stores in Japan from September 14, 2026, excluding some locations. The DASH line will also be sold at selected FamilyMart stores in southern Kyushu and Okinawa. Snowplus simultaneously named Japanese rock band Kishidan as a brand ambassador, combining convenience-store distribution with a broader consumer marketing push in Japan.
Sep.15
BAT Calls for Retailer Input in Future Nicotine Regulations
BAT Calls for Retailer Input in Future Nicotine Regulations
British American Tobacco (BAT) has called for stronger retailer involvement in shaping future nicotine product regulations in the UK, arguing that frontline market feedback should be considered during policy development. BAT said retailers provide direct insight into consumer behavior, market changes and regulatory implementation challenges. The comments come as the UK nicotine market undergoes regulatory changes, including the disposable vape ban, Vaping Products Duty and efforts to address illicit vape sales.
Jul.29
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19